Survey reveals skyrocketing interest in marijuana and cannabinoids for pain. These Companies are aggressively building for this consumer confidence:
August 27, 2019 -- InvestorsHub NewsWire -- via Corporate Ads --
The Target Group (OTCQB: CBDY)
Positioned to Serve the New Legal Cannabis Marketplace with High Quality Supply Sources, an innovative herbal vaporizer system and its Own Established Growth Facility.
Based in Ontario, Canada is a progressive, diversified, and vertically integrated cannabis investment company. CBDY has completed an impressive growth facility and is expanding operations to build an international network of manufacturing, distribution, production, and sales operations. This company is creating an iconic brand portfolio, leveraging product diversification, innovation, and operational expertise to solidify long-term growth and stability.
Target Group, with the very appropriate trading symbol of CBDY, is positioned with the assets, professional management experience and specific industry expertise to address the needs of the new cannabis related businesses emerging today.
In May of 2019 CBDY's wholly owned subsidiary, Canary Rx Inc. completed the build-out of a new 44,000 sq. ft. cannabis production facility in Norfolk County, Ontario. The production area is equipped with sophisticated environmental control technology, custom-built to regulate eight 2,200 sq. ft. flower rooms as well as vegetative, breeding, testing, and curing spaces. Once fully operational, this facility expected to produce 3,600kg of premium, organic cannabis per year.
Also in Target Group's Portfolio[KM1] is CannaKorp, Inc., which has developed the world's first single-use pod, herbal vaporizer system, delivering unprecedented quality, convenience and consistency. The complete system includes the ground breaking vaporizer device, WISP™, single-use, precisely measured pods containing pre-ground, lab-tested botanical herbs called WISP Pods™; and a proprietary pod-filling process. CannaKorp, Inc. was founded on care and commitment to patients and consumers, and is guided by a philosophy of social and environmental responsibility.
In summary, Target Group (CBDY) is at a pivotal moment where an entire industry is just coming into play and this company is ready to participate in a very significant role. Learn more via the company websites:
Target Group, Inc. www.targetgroupinc.ca and Canary Rx Inc. www.canaryrx.com
Canopy Growth Corp. (CGC)
The first Canadian marijuana company, Canopy Growth Corp. is the world's largest publicly traded weed company.
The company owns and operates many brands, producing and marketing both medical and recreational strains. Tweed is one of the company's most popular brands, thanks to an association with rapper Snoop Dogg. For its 2019 fiscal year, it reported revenue of CAD 77.9 million or nearly $60 million.
Acacia Diversified Holdings (OTCQB: ACCA)
Positioned for a Key Role as a Trusted Supplier of Optimized Medical Cannabis Solutions
The ACCA growth facilities, located in both Florida and Tennessee, are situated indoors which offer distinct advantages, particularly a much more controlled environment. In February 2019 ACCA announced that its wholly-owned subsidiary Eufloria Medical of Tennessee, had entered into a Hemp Research Partnership with Tennessee State University (TSU). Eufloria Medical will produce the cannabis material for this important study. In May, Eufloria also reported that it has completed phase one of the construction work for 16,000 Sq./ft of the indoor space at its Tennessee farm. Phase two is underway now with specialized equipment being installed.
Aurora Cannabis Inc. (ACB)
Another big Canadian pot company, Aurora Cannabis became even bigger in March by acquiring rival MedReleaf in a $250 million all-stock deal that was touted as the world's largest marijuana deal to date.
Consolidating operations will help the new entity cut costs and gain efficiency. According to a press release, Aurora and MedReleaf together expect to produce over 570,000 kilograms per year of cannabis through nine facilities in Canada and two in Denmark.
Aurora debuted on the Canadian venture stock exchange (TSX) in October 2016 and trades in the U.S. on the NYSE. https://www.auroramj.com/
Cronos Group Inc. (CRON)
Nasdaq's first pot stock, Cronos Group is a Toronto-based cultivator of medical marijuana.
In addition to Canada, Cronos serves international markets, shipping its products to Germany, building a facility in Israel, and starting a joint venture in Australia. Cronos Group does not have a presence in the U.S. due to the uncertainty in regulations.
As of its 2018 fiscal year, the company generated $7.3 million in revenue.
DISCLAIMER: CorporateAds.com (CA) is a third-party publisher and news dissemination service provider. CA is NOT affiliated in any manner with any company mentioned herein. CA is news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. CA's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release or opinion of the writer. CA is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. CA has been compensated $1,000.00 for this release and HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur.